| Literature DB >> 30269065 |
Federica Dellafiore1, Cristina Arrigoni2, Francesco Pittella1, Gianluca Conte1, Arianna Magon1, Rosario Caruso1.
Abstract
AIM: The aim of this study was to critically analyse and describe gender differences related to self-care among patients with chronic heart failure (HF). METHODS ANDEntities:
Keywords: cardiology; clinical governance; heart failure
Mesh:
Year: 2018 PMID: 30269065 PMCID: PMC6169756 DOI: 10.1136/bmjopen-2018-021966
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Sample characteristics (n=346)
| Demography | N (%) | |
| Mean (SD) | Age (years) | 65.6 (13.6) |
| Gender (male/female) | 61.1%/38.9% | |
| Nationality (Italian) | 100% | |
| Anthropometry | ||
| Mean (SD) | Body mass index (kg/m2) | 26.95 (4.97) |
| Clinical characteristics | ||
| Class II | 256 (74.0%) | |
| Class III | 82 (23.7%) | |
| Class IV | 8 (2.3%) | |
| reduced Ejection Fraction (<40%) | 82 (23.7%) | |
| Mid-range Ejection Fraction (40%–50%) | 101 (29.2%) | |
| Preserved ejection fraction (≥50%) | 163 (47.1%) | |
| Cumulative Illness Rating Scale (CIRS) total score 0 | 270 (78.0%) | |
| CIRS total score 1 | 50 (14.5%) | |
| CIRS total score 2 | 26 (7.5%) | |
| Secondary cardiac diagnosis | ||
| Myocardial Infarction | 225 (65.0%) | |
| Hypertension | 176 (50.9%) | |
| Atrial fibrillation | 111 (30.1%) | |
| Drug treatment | ||
| ACE inhibitors | 73 (21.1%) | |
| B-blockers | 87 (25.1%) | |
| Diuretics | 270 (78.0%) | |
| Cardiac glycosides | 160 (46.2%) | |
| Aspirin or salicylates | 222 (64.2%) | |
| Calcium channel blockers | 74 (21.4%) | |
| ‘Adequate’ self-care (scores ≥70) | ||
| Maintenance | 66 (18.0%) | |
| Management | 28 (7.6%) | |
| Confidence | 131 (35.7%) | |
Models of logistic regression analysis
| Maintenance | |||||||
| Predictors | Wald’s χ2 | df | P values | OR | 95% CI | ||
| Constant | 2.356 | 1 | 0.125 | – | – | ||
| Confidence (adequate vs inadequate) | 4.767 | 1 | 0.029 | 0.188 | 0.042 to 0.843 | ||
| Management (adequate vs inadequate) | 4.413 | 1 | 0.036 | 0.182 | 0.037 to 0.892 | ||
| CIRS | 2.314 | 1 | 0.128 | 2.909 | 0.735 to 11.512 | ||
| Gender (male vs female) | 4.232 | 1 | 0.04 | 4.596 | 1.075 to 19.650 | ||
| Model | χ2 | df | P values | Pseudo-R2
| Pseudo-R2
| Pseudo-R2
| |
| Likehood ratio test | 18.69 | 9 | 0.028 | 0.241 | 0.351 | 0.238 | |
| Hosmer-Lemeshow test | 4.185 | 6 | 0.665 | – | – | – | |
| Management | |||||||
| Predictors | Wald’s χ2 | df | P values | OR | 95% CI | ||
| Constant | 0.799 | 1 | 0.271 | – | – | ||
| Confidence (adequate vs inadequate) | 1.992 | 1 | 0.158 | 0.318 | 0.065 to 1.561 | ||
| Maintenance (adequate vs inadequate) | 4.902 | 1 | 0.027 | 0.171 | 0.036 to 0.816 | ||
| CIRS | 0.265 | 1 | 0.607 | 0.729 | 0.219 to 2.429 | ||
| Gender (male vs female) | 0.88 | 1 | 0.348 | 2.126 | 0.440 to 10.284 | ||
| Model | χ2 | df | P values | Pseudo-R2
| Pseudo-R2
| Pseudo-R2
| |
| Likehood ratio test | 16.3 | 9 | 0.049 | 0.218 | 0.336 | 0.241 | |
| Hosmer-Lemeshow test | 3.404 | 6 | 0.696 | – | – | – | |
| Confidence | |||||||
| Predictors | Wald’s χ2 | df | P values | OR | 95% CI | ||
| Constant | 2.758 | 1 | 0.097 | – | – | ||
| Maintenance (adequate vs inadequate) | 4.644 | 1 | 0.031 | 0.211 | 0.051 to 0.869 | ||
| Management (adequate vs inadequate) | 1.906 | 1 | 0.167 | 0.332 | 0.069 to 1.589 | ||
| CIRS | 4.953 | 1 | 0.026 | 0.297 | 0.102 to 0.865 | ||
| Gender (male vs female) | 1.474 | 1 | 0.035 | 0.412 | 0.104 to 0.962 | ||
| Model | χ2 | df | P values | Pseudo-R2
| Pseudo-R2
| Pseudo-R2
| |
| Likehood ratio test | 17.8 | 9 | 0.044 | 0.221 | 0.314 | 0.221 | |
| Hosmer-Lemeshow test | 1.604 | 4 | 0.708 | – | – | – | |
CIRS, Cumulative Illness Rating Scale.